Vivo Capital, LLC Selecta Biosciences Inc Transaction History

Vivo Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$1.64 - $3.42 $1.55 Million - $3.24 Million	-947,175 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$2.18 - $2.84 $2.85 Million - $3.72 Million	-1,308,606 Reduced 58.01%	947,175 $2.35 Million
Q2 2020 Aug 14, 2020	SELL	$1.83 - $4.06 $10.2 Million - $22.7 Million	-5,590,728 Reduced 71.25%	2,255,781 $6.41 Million
Q1 2020 May 15, 2020	BUY	$1.5 - $4.52 $11.8 Million - $35.5 Million	7,846,509 New	7,846,509 $18.9 Million
Q3 2019 Nov 13, 2019	SELL	$1.6 - $2.08 $873,686 - $1.14 Million	-546,054 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$2.66 - $15.93 $572,429 - $3.43 Million	-215,199 Reduced 28.27%	546,054 $1.45 Million
Q3 2018 Nov 13, 2018	SELL	$12.07 - $16.0 $233,530 - $309,568	-19,348 Reduced 2.48%	761,253 $11.8 Million
Q2 2018 Aug 10, 2018	SELL	$9.36 - $13.25 $3.17 Million - $4.49 Million	-338,588 Reduced 30.25%	780,601 $10.3 Million
Q3 2017 Nov 13, 2017	BUY	$15.22 - $20.03 $17 Million - $22.4 Million	1,119,189	1,119,189 $20.4 Million

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.